louisiana glp-1 gastric intestinal obstruction lawsuit gastrointestinal class action Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Ozempic Lawsuit Update May 2026
Description
Synthetic versions of the GLP-1 hormone for weight loss, manufactured in labs, last much longer, helping you feel fuller for longer and reducing appetite
A combined 20% earned between $20,000$39,999 or 15,00029,999, and 12% earned under $20,000 or 15,000
Nausea is the most common side effect, which generally subsides as a persons body adjusts to the medication
Generic drugs do have to show like bioequivalence to their branded analogues. There is currently no generic Ozempic in the United States
